
ACAD vs ERAS
$ACAD vs $ERAS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ACAD vs ERAS: the quick read
- ·ERAS is the larger company by market cap ($4.64B vs $3.66B).
- ·ERAS has been more active on our scanner (167 vs 83 alerts in 30 days).
- ·ACAD has the smaller float (169.6M vs 303.9M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 167 and 83 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 27% of each other on market cap, which makes the rest of this table the interesting part.
- ·ACAD is the one in play today, trading about 2.9x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ACAD and ERAS on TheDesperateTrader.
- Is ACAD or ERAS the better stock?
- "Better" depends on your goal, and these two are not alike. ERAS is the larger company by market cap ($4.64B vs $3.66B). ERAS has been more active on our scanner (167 vs 83 alerts in 30 days). ACAD has the smaller float (169.6M vs 303.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ACAD and ERAS?
- The differences that matter: they are similar in size ($3.66B vs $4.64B); they trade at very different share prices ($21.20 vs $13.00); ACAD sits at 22% of its 52-week range against 49% for ERAS; our scanner flagged ACAD 83 times in the last 30 days against 167 for ERAS. Everything above is measured from the latest completed session and SEC filings.
- Which of ACAD and ERAS is more active right now?
- Right now ACAD is at about 2.9x its normal volume and ERAS is at about 1.4x, so ACAD is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ACAD or ERAS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ACAD and ERAS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.